J84-Coded Interstitial Lung Disease Co-Certification in U.S. Deaths Attributed to Intracerebral or Subarachnoid Hemorrhage, 1999–2024: a Serial Cross-Sectional Study

Abstract Background National death-certificate co-certification of J84-coded interstitial lung disease (ILD) with deaths attributed to intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH) has not been characterized. We quantified this coding-defined intersection in the United States. Methods We performed a serial cross-sectional analysis of CDC WONDER Multiple Cause of Death data for 1999–2024. Deaths were included when I60 or I61 was the underlying cause and J84 was listed as a multiple cause. Primary estimands were the aggregate co-certification proportion and hemorrhage-subtype distribution. A 95% Wilson confidence interval was calculated for the overall co-certification proportion. Segmented Poisson modeling was limited to the complete combined J84 series; series with suppressed annual cells were not trend-modeled because suppression is informative. Results Among 604,331 U.S. deaths attributed to SAH or ICH, 551 carried J84, an aggregate co-certification proportion of 0.091% (95% CI, 0.084%–0.099%); 437 were ICH and 114 were SAH. The combined crude population mortality rate was 0.050 per 1,000,000 in 1999 and 0.100 in 2024. A secondary exploratory model of the complete combined J84 series selected a 2012 change point, but this model used the U.S. population rather than annual fatal SAH/ICH deaths as its denominator. J84.1 accounted for 410 co-certified deaths (74.4%); its annual trend was not modeled because the 2009 cell was suppressed. SAH-specific, sex-interaction, and exact COVID-exclusion trends were not estimable. Conclusions J84-coded ILD was rarely co-certified among deaths attributed to SAH or ICH. These data provide a national surveillance baseline with a precisely estimated but very small aggregate co-certification proportion. Secondary crude population-rate trends do not measure annual ILD representation among fatal hemorrhagic-stroke deaths, and subgroup trends with suppressed years were not estimated.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-11310894/v1
Primary Topic
Intracerebral and Subarachnoid Hemorrhage Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

J84-Coded Interstitial Lung Disease Co-Certification in U.S. Deaths Attributed to Intracerebral or Subarachnoid Hemorrhage, 1999–2024: a Serial Cross-Sectional Study

Christina Cacoulidis, Travis Homan
4 links
Research Square
Intracerebral and Subarachnoid Hemorrhage Research
preprint

J84-Coded Interstitial Lung Disease Co-Certification in U.S. Deaths Attributed to Intracerebral or Subarachnoid Hemorrhage, 1999–2024: a Serial Cross-Sectional Study

Christina Cacoulidis, Travis Homan
preprint en

Abstract

Abstract Background National death-certificate co-certification of J84-coded interstitial lung disease (ILD) with deaths attributed to intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH) has not been characterized. We quantified this coding-defined intersection in the United States. Methods We performed a serial cross-sectional analysis of CDC WONDER Multiple Cause of Death data for 1999–2024. Deaths were included when I60 or I61 was the underlying cause and J84 was listed as a multiple cause. Primary estimands were the aggregate co-certification proportion and hemorrhage-subtype distribution. A 95% Wilson confidence interval was calculated for the overall co-certification proportion. Segmented Poisson modeling was limited to the complete combined J84 series; series with suppressed annual cells were not trend-modeled because suppression is informative. Results Among 604,331 U.S. deaths attributed to SAH or ICH, 551 carried J84, an aggregate co-certification proportion of 0.091% (95% CI, 0.084%–0.099%); 437 were ICH and 114 were SAH. The combined crude population mortality rate was 0.050 per 1,000,000 in 1999 and 0.100 in 2024. A secondary exploratory model of the complete combined J84 series selected a 2012 change point, but this model used the U.S. population rather than annual fatal SAH/ICH deaths as its denominator. J84.1 accounted for 410 co-certified deaths (74.4%); its annual trend was not modeled because the 2009 cell was suppressed. SAH-specific, sex-interaction, and exact COVID-exclusion trends were not estimable. Conclusions J84-coded ILD was rarely co-certified among deaths attributed to SAH or ICH. These data provide a national surveillance baseline with a precisely estimated but very small aggregate co-certification proportion. Secondary crude population-rate trends do not measure annual ILD representation among fatal hemorrhagic-stroke deaths, and subgroup trends with suppressed years were not estimated.

Research Square
St. Luke's Hospital (US), St. Luke's Hospital (US), University of Missouri–Kansas City (US)
Good health and well-being
Intracerebral and Subarachnoid Hemorrhage Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon